L 2005, 15(12):666?73. Sartorelli V, Caretti G: Mechanisms underlying the transcriptional regulation of skeletal myogenesis. Curr Opin Genet Dev 2005, 15(5):528?35. Ferri P, Barbieri E, Burattini S, Guescini M, D’Emilio A, Biagiotti L, Del Grande P, De Luca A, Stocchi V, Falcieri E: Expression and subcellular localization of myogenic regulatory factors throughout the differentiation of skeletal muscle C2C12 myoblasts. J Cell Biochem 2009, 108(6):1302?317. Perry RL, Rudnick MA: Molecular mechanisms regulating myogenic determination and differentiation. Front Biosci 2000, five:D750 767. Ostrovsky O, Bengal E: The mitogen-activated protein kinase cascade promotes myoblast cell survival by stabilizing the cyclin-dependent kinase inhibitor, p21WAF1 protein. J Biol Chem 2003, 278(23):21221?1231. Naya FJ, Olson E: MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol 1999, 11(6):683?88. Abmayr SM, Zhuang S, Geisbrecht ER: Myoblast fusion in Drosophila. Procedures Mol Biol 2008, 475:75?7. Taulet N, Comunale F, Favard C, Charrasse S, Bodin S, Gauthier-Rouvi e C: N-cadherin/p120 catenin association at cell-cell contacts occurs in cholesterol-rich membrane domains and is essential for RhoA activation and myogenesis. J Biol Chem 2009, 284(34):23137?3145. Sj lom B, Salmazo A, Djinovi-Carugo K: Alpha-actinin structure and regulation. Cell Mol Life Sci 2008, 65(17):2688?701. Coleman ME, DeMayo F, Yin KC, Lee HM, Geske R, Montgomery C, Schwartz RJ: Myogenic vector expression of insulin-like development element I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 1995, 270(20):12109?2116. DeVol DL, Rotwein P, Sadow JL, Novakofski J, Bechtel PJ: Activation of insulin-like development factor gene expression through work-induced skeletal muscle development. Am J Physiol 1990, 259(1 Pt 1):E89 95. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD: Akt/ mTOR pathway can be a vital regulator of skeletal muscle hypertrophy and may stop muscle atrophy in vivo.4-Chloro-6-methoxypyridin-2-amine structure Nat Cell Biol 2001, three:1014?019.1107658-78-5 manufacturer Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ: Conditional activation of aktSenesi et al.PMID:24140575 Journal of Translational Medicine 2013, 11:174 http://translational-medicine/content/11/1/Page 12 of33.34.35.36. 37.38.39.40.41.42.43.44. 45.46. 47.48. 49.50.51.52.in adult skeletal muscle induces speedy hypertrophy. Mol Cell Biol 2004, 24:9295?304. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ: Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(three)K/Akt/GSK3 pathways. Nat Cell Biol 2001, three(11):1009?013. Burattini S, Ferri P, Battistelli M, Curci R, Luchetti F, Falcieri E: C2C12 murine myoblasts as a model of skeletal muscle improvement: A morpho functional characterization. Eur J Histochem 2004, 48(three):223?33. Terruzzi I, Senesi P, Magni C, Montesano A, Scarafoni A, Luzi L, Duranti M: Insulin-mimetic action of conglutin-, a lupin seed protein, in mouse myoblasts. Nutr Metab Cardiovasc Dis 2011, 21(three):197?05. Pavlath GK: Spatial and functional restriction of regulatory molecules for the duration of mammalian myoblast fusion. Exp Cell Res 2010, 316:3067?072. Musar?A, Rosenthal N: Maturation of the myogenic plan is induced by postmitotic expression of insulin-like growth aspect I. Mol Cell.